172 related articles for article (PubMed ID: 21565479)
21. The metabolic syndrome and nonalcoholic fatty liver disease.
Collantes RS; Ong JP; Younossi ZM
Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331
[TBL] [Abstract][Full Text] [Related]
22. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
[No Abstract] [Full Text] [Related]
23. Diagnosis and management of the metabolic syndrome in obesity.
Liberopoulos EN; Mikhailidis DP; Elisaf MS
Obes Rev; 2005 Nov; 6(4):283-96. PubMed ID: 16246214
[TBL] [Abstract][Full Text] [Related]
24. New approaches in the intensive management of cardiovascular risk in the metabolic syndrome.
Rosenson RS
Curr Probl Cardiol; 2005 May; 30(5):241-79. PubMed ID: 15829899
[TBL] [Abstract][Full Text] [Related]
25. Management of metabolic syndrome in young population.
Brandão AP; Brandão AA; de Magalhães ME; Pozzan R
Am J Ther; 2008; 15(4):356-61. PubMed ID: 18645340
[TBL] [Abstract][Full Text] [Related]
26. How should we manage patients with non-alcoholic fatty liver disease in 2007?
Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
[TBL] [Abstract][Full Text] [Related]
27. Management of metabolic syndrome in morbidly obese children and adolescents.
Quintos JB; Castells S
Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():564-70. PubMed ID: 17237744
[TBL] [Abstract][Full Text] [Related]
28. Type 2 diabetes in children and adolescents--the next epidemic?
Vivian EM
Curr Med Res Opin; 2006 Feb; 22(2):297-306. PubMed ID: 16466601
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular risk: prevention and treatment of the metabolic syndrome.
Tuomilehto J
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S28-35. PubMed ID: 15953504
[TBL] [Abstract][Full Text] [Related]
30. The dilemma of the metabolic syndrome in children and adolescents: disease or distraction?
Jones KL
Pediatr Diabetes; 2006 Dec; 7(6):311-21. PubMed ID: 17212598
[TBL] [Abstract][Full Text] [Related]
31. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
l'Allemand-Jander D
Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S32-6. PubMed ID: 21151144
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic fatty liver disease in children now: lifestyle changes and pharmacologic treatments.
Alisi A; Nobili V
Nutrition; 2012 Jul; 28(7-8):722-6. PubMed ID: 22464551
[TBL] [Abstract][Full Text] [Related]
33. Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.
Lebovics E; Rubin J
Diabetes Metab Res Rev; 2011 Jul; 27(5):419-24. PubMed ID: 21425426
[TBL] [Abstract][Full Text] [Related]
34. Long chain omega-3 polyunsaturated fatty acids in pediatric metabolic syndrome.
Pacifico L; Giansanti S; Gallozzi A; Chiesa C
Mini Rev Med Chem; 2014; 14(10):791-804. PubMed ID: 25307311
[TBL] [Abstract][Full Text] [Related]
35. Physical activity as the main therapeutic tool for metabolic syndrome in childhood.
Brambilla P; Pozzobon G; Pietrobelli A
Int J Obes (Lond); 2011 Jan; 35(1):16-28. PubMed ID: 21139560
[TBL] [Abstract][Full Text] [Related]
36. The metabolic syndrome and the liver.
Verrijken A; Francque S; Van Gaal L
Acta Gastroenterol Belg; 2008; 71(1):48-59. PubMed ID: 18396752
[TBL] [Abstract][Full Text] [Related]
37. Current and emerging therapies in nonalcoholic fatty liver disease.
Kashi MR; Torres DM; Harrison SA
Semin Liver Dis; 2008 Nov; 28(4):396-406. PubMed ID: 18956296
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents.
Molnár D
Int J Obes Relat Metab Disord; 2004 Nov; 28 Suppl 3():S70-4. PubMed ID: 15543223
[TBL] [Abstract][Full Text] [Related]
39. The role of medicinal chemistry in treating obesity, diabetes and metabolic syndrome.
Ortúzar N
ChemMedChem; 2013 Apr; 8(4):535-7. PubMed ID: 23529925
[No Abstract] [Full Text] [Related]
40. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification.
Cruz ML; Shaibi GQ; Weigensberg MJ; Spruijt-Metz D; Ball GD; Goran MI
Annu Rev Nutr; 2005; 25():435-68. PubMed ID: 16011474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
